Home > Insider Trading > Filing (0001567619-19-013840)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1623526	Stoke Therapeutics Inc.	STOK	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1404955	Loring Seth Harrison	C/O Stoke Therapeutics, Inc. 45 Wiggins Avenue Bedford MA 01730		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-06-21	4,980,168	$0.00	4,980,168	No	4	C	Indirect	By Apple Tree Partners IV, L. P
Common Stock	Acquisiton	2019-06-21	7,617,746	$0.00	12,597,914	No	4	C	Indirect	By Apple Tree Partners IV, L. P
Common Stock	Acquisiton	2019-06-21	2,799,910	$0.00	15,397,824	No	4	C	Indirect	By Apple Tree Partners IV, L. P
Common Stock	Acquisiton	2019-06-21	1,388,889	$18.00	16,786,713	No	4	P	Indirect	By Apple Tree Partners IV, L. P

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Apple Tree Partners IV, L. P
No	4	C	Indirect	By Apple Tree Partners IV, L. P
No	4	C	Indirect	By Apple Tree Partners IV, L. P
No	4	P	Indirect	By Apple Tree Partners IV, L. P

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2019-06-21	4,980,168	$0.00	4,980,168	$0.00
Common Stock	Series A-2 Convertible Preferred Stock	Disposition	2019-06-21	7,617,746	$0.00	7,617,746	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2019-06-21	2,799,910	$0.00	2,799,910	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

The shares of Series A Convertible Preferred Stock, Series A-2 Convertible Preferred Stock, Series B Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1-for-1 basis upon the closing of the Issuer's initial public offering on June 21, 2019.
Apple Tree Partners IV, L.P. ("ATP IV"). ATP III GP, Ltd. ("ATP III"), is the sole general partner of ATP IV. Reporting Person is the sole director of ATP III and may be deemed to have sole voting and dispositive power over the shares held by ATP IV. Dr. Harrison disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.